<DOC>
	<DOC>NCT02746068</DOC>
	<brief_summary>This is a randomized, double-blind, placebo-controlled, 24-week study to evaluate the efficacy and safety of AXS-02 in subjects with knee osteoarthritis associated with bone marrow lesions.</brief_summary>
	<brief_title>A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>Key Male at least 50 years of age, or postmenopausal female Meets the ACR clinical criteria for knee osteoarthritis Bone Marrow Lesion of the knee present on MRI Additional criteria may apply Key Previous surgery on index knee Any prior use of bisphosphonates within 6 months of screening Additional criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Bone Marrow Lesions</keyword>
	<keyword>AXS02</keyword>
	<keyword>Axsome</keyword>
	<keyword>Knee OA</keyword>
	<keyword>Osteoarthritis</keyword>
</DOC>